Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, November 29, 2009, 6:32AM ET - U.S. Markets Closed. Dow Down 1.48% Nasdaq Down 1.73%
Regeneron Pharmaceuticals Inc. (REGN)On Nov 27: 18.09  Down 0.25 (1.36%)  
MORE ON REGN
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
PERIOD ENDING31-Dec-0831-Dec-0731-Dec-06
Total Revenue238,457  125,024  63,447  
Cost of Revenue923   -  8,146  
Gross Profit237,534  125,024  55,301  
Operating Expenses
Research Development278,016  201,613  137,064  
Selling General and Administrative49,348  37,865  25,892  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss(89,830)(114,454)(107,655)
Income from Continuing Operations
Total Other Income/Expenses Net17,223  20,897  16,548  
Earnings Before Interest And Taxes(72,607)(93,557)(91,107)
Interest Expense7,752  12,043  12,043  
Income Before Tax(80,359)(105,600)(103,150)
Income Tax Expense2,351   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(82,710)(105,600)(103,150)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -  813  
Other Items -   -   -  
Net Income(82,710)(105,600)(102,337)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares($82,710)($105,600)($102,337)

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol: Symbol Lookup
Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More